Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Brent Saunders
Brent Saunders
Bausch + Lomb's Saunders doesn't expect more big deals in the near term
Bausch + Lomb's Saunders doesn't expect more big deals in the near term
Reuters
Bausch + Lomb
Pharma CEOs
Brent Saunders
earnings
M&A
Flag link:
Brent Saunders to Return as Bausch + Lomb CEO
Brent Saunders to Return as Bausch + Lomb CEO
US News Money
Brent Saunders
Bausch + Lomb
Joseph Papa
Pharma CEOs
Flag link:
Low-profile eye drop developer spells out the game plan that drew Brent Saunders to the board — and it involves going earlier than anti-VEGFs
Low-profile eye drop developer spells out the game plan that drew Brent Saunders to the board — and it involves going earlier than anti-VEGFs
Endpoints
OcuTerra
diabetic retinopathy
wet age-related macular degeneration
Brent Saunders
Flag link:
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
NASDAQ
Vesper Healthcare Acquisition
Brent Saunders
Allergan
SPAC
IPOs
Flag link:
Allergan ex-CEO Saunders takes board seat at BridgeBio
Allergan ex-CEO Saunders takes board seat at BridgeBio
Fierce Biotech
Brent Saunders
Pharma CEOs
Allergan
BridgeBio
Flag link:
Allergan CEO Saunders lines up for $39M parachute after AbbVie buy
Allergan CEO Saunders lines up for $39M parachute after AbbVie buy
Fierce Pharma
Allergan
executive pay
Pharma CEOs
Brent Saunders
AbbVie
M&A
Flag link:
How Brent Saunders’ Allergan experiment failed
How Brent Saunders’ Allergan experiment failed
Stat
Brent Saunders
Allergan
AbbVie
Pharma CEOs
Flag link:
Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
Allergan chief Saunders takes a painful $2.5B hit on an ugly PhIII flop
Endpoints
Allergan
Brent Saunders
Flag link:
Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics
Allergan CEO Saunders hangs on to chairman's title, winning shareholder support — but not by a big enough margin to squelch critics
Endpoints
Allergan
Pharma CEOs
Brent Saunders
Flag link:
‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp
‘Something needs to change’: An Allergan analyst spells out why next week’s vote could still spark a major revamp
Endpoints
Allergan
Brent Saunders
shareholders
Flag link:
Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan
Influential proxy firms kick back at activists’ demands for Brent Saunders to give up his chairman’s title at Allergan
Endpoints
Allergan
Brent Saunders
activists
Flag link:
What do Allergan activists really want? A new CEO to replace Saunders, analyst says
What do Allergan activists really want? A new CEO to replace Saunders, analyst says
Fierce Pharma
Allergan
activists
Pharma CEOs
Brent Saunders
Flag link:
Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs
Sorry, Allergan. Another activist backs an immediate split to CEO, chairman jobs
Fierce Pharma
Allergan
Brent Saunders
Pharma CEOs
Flag link:
Under-pressure Allergan backs a CEO-chairman job split—just not right now
Under-pressure Allergan backs a CEO-chairman job split—just not right now
Fierce Pharma
Allergan
Pharma CEOs
Brent Saunders
Flag link:
What's next for embattled Allergan? Depends on pipeline performance, analysts say
What's next for embattled Allergan? Depends on pipeline performance, analysts say
Fierce Pharma
Allergan
Brent Saunders
reorganization
Flag link:
Old CEO, new chairman? Some Allergan investors want Pyott to come back: report
Old CEO, new chairman? Some Allergan investors want Pyott to come back: report
Fierce Pharma
Pharma CEOs
Allergan
Brent Saunders
David Pyott
Flag link:
Saunders: All options remain on the table for Allergan
Saunders: All options remain on the table for Allergan
Biopharma Dive
Allergan
Pharma CEOs
Brent Saunders
Flag link:
Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening
Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening
Fierce Pharma
Allergan
Pharma CEOs
Brent Saunders
spinoffs
Flag link:
Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package
Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package
Endpoints
executive pay
Pharma CEOs
Allergan
Brent Saunders
Alex Gorsky
Richard Gonzalez
Flag link:
Don't expect Restasis generics till at least next quarter, Allergan CEO says
Don't expect Restasis generics till at least next quarter, Allergan CEO says
Fierce Pharma
Allergan
Pharma CEOs
Brent Saunders
Restasis
generics
JPMHC 2018
Flag link:
Pages
1
2
3
4
next ›
last »